CD8A and amyotrophic lateral sclerosis: The highest levels of IFN-γ spots or secretion were found in CD8+ T cells treated with anti-CD3/CD28 antibodies, and the levels were significantly higher in ALS patients’ CD8+ T cells in comparison to healthy controls.